Today, Committee Democrats convened a markup of H.R. 3, a radical drug pricing scheme that eliminates choice and competition, and jeopardizes innovation, investment, and access to future cures.
“H.R. 3 is nothing more than a down payment on Medicare for All, a government-run health care system that would eliminate private insurance. Today’s markup is another example of the Committee’s focus on radical socialist priorities including one-size-fits-all mandated minimum wage hikes, trial-lawyer rewards, taxpayer-funded pension bailouts, and heavy-handed government intervention targeting small businesses,” Republican Leader Virginia Foxx (R-NC) said in her opening statement. “We shouldn’t be pursuing policies that will harm the health and well-being of American patients. And we shouldn’t destroy a system that allows the U.S. to lead the world in new cures and treatments.”
“In the past, Democrats and Republicans have come together to work in a bipartisan manner to tackle this issue, but during a time of unparalleled political divide, my colleagues have decided to pursue politics over progress,” Rep. Tim Walberg (R-MI) said in his statement opposing the Democrats’ Amendment in the Nature of a Substitute.
Background: The Democrats’ Amendment in the Nature of a Substitute offered at today’s markup makes this bad bill even worse. By creating an even more extreme bill, the Democrats are stripping patients and families of choices and treatments to appease a group of far-left members.
Republicans stand ready to work with Democrats to push for legislation that promotes competition, lowers out-of-pocket costs for consumers, and establishes transparency and accountability in drug pricing.